Jagsonpal Pharma Financials
NSE: JAGSNPHARM | BSE: 507789
₹241.54
₹-0.52
(-0.21%)
As on 07-Sep-2026 11:39IST
Market cap
₹1,590 Cr
Revenue (TTM)
₹294 Cr
P/E Ratio
35
P/B Ratio
6.9
Div. Yield
2.3 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
293.85
|
287.23
|
268.72
|
208.70
|
236.71
|
217.58
|
|
|
|
|
|
|
Total Income
|
305.85
|
299.22
|
276.91
|
217.98
|
242.45
|
221.01
|
|
|
|
|
|
|
Total Expenditure
|
232.74
|
229.15
|
217.65
|
185.64
|
202.56
|
192.56
|
|
|
|
|
|
|
EBITDA
|
61.10
|
--
|
--
|
23.07
|
34.15
|
25.03
|
|
|
|
|
|
|
Depreciation
|
9.23
|
9.44
|
8.13
|
1.66
|
1.21
|
1.53
|
|
|
|
|
|
|
EBIT
|
51.87
|
--
|
--
|
21.40
|
32.95
|
23.50
|
|
|
|
|
|
|
Interest
|
1.03
|
1.03
|
0.96
|
0.81
|
0.41
|
0.29
|
|
|
|
|
|
|
Other Income
|
12.00
|
12.00
|
8.19
|
9.28
|
5.73
|
3.43
|
|
|
|
|
|
|
Exceptional Items
|
-2.08
|
-2.08
|
19.69
|
--
|
-3.46
|
--
|
|
|
|
|
|
|
Profit before Tax
|
60.77
|
57.52
|
69.86
|
29.87
|
34.81
|
26.64
|
|
|
|
|
|
|
Provision for Tax
|
15.29
|
14.44
|
14.50
|
7.41
|
8.09
|
7.79
|
|
|
|
|
|
|
Profit after Tax
|
45.48
|
43.08
|
55.36
|
22.46
|
26.72
|
18.86
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
276.17
|
276.17
|
239.95
|
187.40
|
158.89
|
132.76
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
12.21
|
12.21
|
12.41
|
18.11
|
8.49
|
4.49
|
|
|
|
|
|
|
Current Liabilities
|
28.30
|
40.92
|
25.90
|
19.13
|
35.18
|
34.14
|
|
|
|
|
|
|
Total Liabilities
|
316.68
|
--
|
--
|
224.64
|
202.56
|
171.40
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
78.53
|
173.59
|
117.07
|
27.86
|
30.39
|
55.14
|
|
|
|
|
|
|
Current Assets
|
143.09
|
155.71
|
161.19
|
179.60
|
172.17
|
116.25
|
|
|
|
|
|
|
Total Assets
|
316.68
|
--
|
--
|
224.64
|
202.56
|
171.40
|
|
|
|
|
|
|
Total Debt*
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Current Assets
|
114.79
|
114.79
|
135.29
|
160.47
|
136.99
|
82.11
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
22.34
|
16.17
|
11.22
|
6.09
|
7.96
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
46.81
|
55.11
|
35.17
|
46.66
|
6.91
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-35.65
|
-45.15
|
-24.55
|
-57.67
|
-25.78
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-12.15
|
-11.70
|
-8.91
|
-0.46
|
-17.55
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-0.99
|
-1.73
|
1.71
|
-11.47
|
-36.42
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
7.07
|
6.43
|
8.34
|
3.40
|
4.08
|
2.88
|
|
|
|
|
|
|
Cash EPS (₹)
|
6.89
|
7.84
|
9.56
|
3.65
|
4.26
|
3.11
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
34.91
|
38.18
|
32.83
|
25.77
|
22.92
|
20.27
|
|
|
|
|
|
|
Dividend per Share (₹)
|
2.28
|
5.50
|
2.50
|
2.00
|
2.00
|
1.60
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
6.99
|
8.30
|
13.30
|
17.81
|
2.64
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
7.46
|
10.31
|
11.13
|
14.16
|
3.01
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
22.69
|
33.14
|
17.72
|
24.15
|
21.23
|
|
|
|
|
|
|
ROE (%)
|
17.79
|
18.19
|
28.51
|
14.02
|
18.89
|
15.28
|
|
|
|
|
|
|
ROA (%)
|
15.29
|
14.18
|
22.02
|
10.52
|
14.29
|
11.24
|
|
|
|
|
|
|
EBIT Margin (%)
|
17.65
|
--
|
--
|
10.26
|
13.92
|
10.80
|
|
|
|
|
|
|
Net Margin (%)
|
14.87
|
14.40
|
19.99
|
10.31
|
11.02
|
8.53
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
17.25
|
22.53
|
10.75
|
10.86
|
8.41
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
3.87
|
6.89
|
28.76
|
-11.83
|
8.79
|
15.77
|
|
|
|
|
|
|
EBIT Growth (%)
|
13.66
|
--
|
--
|
-35.04
|
40.20
|
30.61
|
|
|
|
|
|
|
Net Profit Growth (%)
|
12.52
|
-22.18
|
146.45
|
-15.94
|
41.72
|
10.53
|
|
|
|
|
|
|
EPS Growth (%)
|
8.90
|
-22.84
|
145.32
|
-16.70
|
41.72
|
10.53
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
17.30
|
27.98
|
13.46
|
13.08
|
16.36
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
34.95
|
28.65
|
25.90
|
13.17
|
11.37
|
17.43
|
|
|
|
|
|
|
Price / Book Value
|
6.90
|
4.83
|
6.58
|
4.34
|
5.06
|
6.19
|
|
|
|
|
|
|
Dividend Yield (%)
|
2.28
|
2.98
|
1.16
|
1.79
|
1.72
|
1.28
|
|
|
|
|
|
|
EV/EBITDA
|
20.29
|
16.10
|
22.02
|
18.30
|
16.17
|
27.99
|
|
|
|
|
|
|
Close Price (₹)
|
238.10
|
184.03
|
217.20
|
110.64
|
115.92
|
125.42
|
|
|
|
|
|
|
High Price (₹)
|
301.80
|
301.80
|
328.04
|
205.94
|
168.08
|
125.44
|
|
|
|
|
|
|
Low Price (₹)
|
154.90
|
154.90
|
109.42
|
108.02
|
100.72
|
30.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
1,589.57
|
1,234.49
|
1,433.90
|
739.87
|
759.47
|
821.58
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
5.06
|
3.81
|
6.22
|
9.39
|
4.89
|
3.40
|
|
|
|
|
|
|
Quick Ratio
|
4.54
|
3.45
|
5.64
|
8.61
|
4.31
|
2.53
|
|
|
|
|
|
|
Interest Coverage
|
60.28
|
56.95
|
73.92
|
37.69
|
85.28
|
94.48
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
5.85
|
5.99
|
4.90
|
5.25
|
8.82
|
7.16
|
|
|
|
|
|
|
Asset Turnover
|
0.99
|
1.00
|
1.12
|
1.05
|
1.38
|
1.45
|
|
|
|
|
|
|
Receivable days
|
--
|
18.20
|
15.63
|
25.88
|
25.87
|
21.26
|
|
|
|
|
|
|
Inventory Days
|
--
|
17.89
|
19.56
|
29.02
|
35.78
|
44.76
|
|
|
|
|
|
|
Payable days
|
--
|
37.27
|
32.80
|
55.17
|
69.43
|
75.08
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-1.18
|
2.39
|
-0.27
|
-7.78
|
-9.07
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
